Stocks · Health care · Pharmaceutical Preparations

Janux Therapeutics, Inc.

JANX Clue Score43
United States Fiscal year ends December CIK 0001817713 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David Alan Campbell
8 Jul 2026
President and CEO
Exercised, kept
7,000
$4.21
$29.47K
Andrew Hollman Meyer
19 Dec 2024
Chief Business Officer
Exercised, kept
1
$14.02
$14.02
Andrew Hollman Meyer
19 Dec 2024
Chief Business Officer
Exercised, kept
9,880
$20.24
$199.97K

What was left out

Form 4 filings counted 136
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 31
Sales at will 60
Transactions with no price 0
Shares from compensation/vesting 36,004,274
Sales filed before the plan box existed 12
History held since 14 Jun 2021